Biomarkers and Personalized Approach to Cancer Group (BioPAC)

Search for publications

Only original articles, editorials, guidelines.

  • Biesma NC, Graus MUJE, Cirkel GA, Besselink MG, de Groot JWB, Koerkamp BG, Herbschleb KH, Los M, Verdonk RC, Wilmink JW, Cervantes A, Valle JW, Valkenburg-van Iersel LBJ, Froeling FEM, Molenaar IQ, Daamen LA, de Vos-Geelen J, van Santvoort HC.

    Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study.

    EJSO . 51(3): 109544-109544.

    [doi:10.1016/j.ejso.2024.109544]

  • Xue N, Sabroso-Lasa S, Merino X, Munzo-Beltran M, Schuurmans M, Olano M, Estudillo L, Ledesma-Carbayo MJ, Liu J, Fan R, Hermans JJ, van Eijck C, Malats N.

    A fusion-based deep-learning algorithm predicts PDAC metastasis based on primary tumour CT images: a multinational study.

    Gut . : .

    [doi:10.1136/gutjnl-2024-334237]

  • López-López C, de Castro EM, Montes AF, Orozco EJ, Peraita SL, Vera R, Cerdá P, Calvo M, Paredes BG, de Mena ML, La Casta A, Gallego J, Adeva J, Cano JMC, Ruiz-Casado A, Vidal-Tocino R, García-García T, Pazo-Cid R, Garrote MR, Sastre J.

    Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-025-04010-z]

  • Panaitescu-Damian A, Gürcinar I, Stoica V, Paiella S, Hollenbach M, Regel I, Swibold D, Capurso G, Carrato A, Michl P, Arnes L.

    Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe.

    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL . : .

    [doi:10.1002/ueg2.70113]

  • Urbanova M, Viol F, Ruiz-Cañas L, Koniaris E, Saksis R, Batres-Ramos S, Earl J, Kataki A, Buocikova V, Burikova M, Cihova M, Rojikova L, Makovicky P, Matuskova M, Kohl Y, Riedmayer A, Makova M, Baciak L, Gogola D, Rogoza O, Rovite V, Sainz B Jr, Smolkova B, Schrader J.

    Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.

    CANCER LETTERS . 634: 218033-218033.

    [doi:10.1016/j.canlet.2025.218033]